[1]
“Formulation and Evaluation of Venlafaxine Sustained-Release Tablets for Improved Patient Compliance: A Comprehensive Review”, IJRDT, vol. 1, no. 1, Aug. 2023, doi: 10.62218/ijrdt.v1i1.86.